Corneal Sensitivity to Hyperosmolar Eye Drops: A Novel Behavioral Assay to Assess Diabetic Peripheral Neuropathy
Matthew S Yorek, Eric P Davidson, Pieter Poolman, Lawrence J Coppey, Alexander Obrosov, Amey Holmes, Randy H Kardon, Mark A Yorek, Matthew S Yorek, Eric P Davidson, Pieter Poolman, Lawrence J Coppey, Alexander Obrosov, Amey Holmes, Randy H Kardon, Mark A Yorek
Abstract
Purpose: Diagnosis of peripheral neuropathy (PN), which affects approximately 50% of the diabetic population, is subjective, with many patients seeking a diagnosis only after presenting with symptoms. Recently, in vivo confocal microscopy of subepithelial corneal nerve density has been promoted as a surrogate marker for early detection of PN, but imaging of corneal nerves requires sophisticated instrumentation, expertise in confocal imaging, cooperative patients, and automated analysis tools to derive corneal nerve density. As an alternative, we developed a simple screening method that is based on the sensitivity of corneal nerves to cause reflex eyelid squinting in response to hyperosmolar eye drops.
Methods: Eyes of control and type 2 diabetic rats were given an eye drop of a 290- to 900-mOsm solution, and the ocular response was video recorded. Other neuropathic end points including nerve conduction velocity and subepithelial cornea nerve density were determined.
Results: Motor and sensory nerve conduction velocity and total nerve fiber length of corneal nerves in the subepithelial layer were significantly decreased in diabetic rats. Applying the hyperosmotic solutions to the ocular surface caused an osmolarity-dependent increase in squinting of the treated eye in control rats. Squinting was almost totally blocked by preapplication of proparacaine or N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide, a transient receptor potential melastatin-8 channel blocker. Squinting in response to the 900-mOsm solution was significantly reduced in diabetic rats.
Conclusions: Preclinical studies show that evaluation of corneal sensitivity may be an alternative method for the early detection of PN and has potential for translation to clinical studies.
Figures
References
- Tesfaye S,, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009; 9: 432–434.
- Hossain P,, Sachdev A,, Malik RA. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet. 2005; 366: 1340–1343.
- Bitirgen G,, Ozkagnici A,, Malik RA,, Kerimoglu H. Corneal nerve fibre damage precedes diabetic retinopathy in patients with type 2 diabetes mellitus. Diabetes Med. 2014; 31: 431–438.
- Ziegler D,, Papanas N,, Zhivov A,, et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. 2014; 63: 2454–2463.
- Malik RA. Which test for diagnosing early human diabetic neuropathy? Diabetes. 2014; 63: 2206–2208.
- Pritchard N,, Edwards K,, Vagenas D,, et al. Corneal sensitivity as an ophthalmic marker of diabetic neuropathy. Optom Vis Sci. 2010; 87: 1003–1008.
- Quallo T,, Vastani N,, Horridge E,, et al. TRPM is a neuronal osmosensor that regulates eye blinking in mice. Nat Commun. 2015; 6: 7150.
- Neira-Zalentein W,, Holopainen JM,, Tervo TMT,, et al. Corneal sensitivity in diabetic patients subjected to retinal laser photocoagulation. Invest Ophthalmol Vis Sci. 2011; 52: 6043–6049.
- Davidson EP,, Coppey LJ,, Calcutt NA,, Oltman CL,, Yorek MA. Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab Res Rev. 2010; 26: 306–318.
- Davidson EP,, Coppey LJ,, Holmes A,, Dake B,, Yorek MA. Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications. Eur J Pharmacol. 2011; 688: 497–506.
- Drel VR,, Pacher P,, Vareniuk I,, et al. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur J Pharmacol. 5007; 569: 48–58.
- Davidson EP,, Coppey LJ,, Holmes A,, Yorek MA. Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat. Invest Ophthalmol Vis Sci. 2012; 53: 1182–1187.
- Schindelin J,, Arganda-Carreras I,, Frise E,, et al. Fiji: An open-source platform for biological-image analysis. Nat Methods. 2012; 9: 676–682.
- Quattrini C,, Tavakoli M,, Jeziorska M,, et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007; 56: 2148–2154.
- Tavakoli M,, Quattrini C,, Abbott C,, et al. Corneal confocal microscopy a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care. 2010; 33: 1792–1797.
- Abe J,, Hosokawa H,, Okazawa M,, et al. TRPM8 protein localization in trigeminal ganglion and taste papillae. Mol Brain Res. 2005; 136: 91–98.
- Obrosova IG,, Li F,, Abatan OI,, et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes. 2004; 53: 711–720.
- Davidson EP,, Coppey LJ,, Yorek MA. Early loss of innervation of cornea epithelium in streptozotocin-induced type 1 diabetic rats: Improvement with ilepatril treatment. Invest Ophthalmol Vis Sci. 2012; 53: 8067–8074.
- Davidson EP,, Coppey LJ,, Kardon RH,, Yorek MA. Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats. Invest Ophthalmol Vis Sci. 2014; 55: 1222–1230.
- Shevalye H,, Yorek MS,, Coppey LJ,, et al. Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes. J Neurophysiol. 2015; 114: 199–208.
- Cai D,, Zhu M,, Petroll M,, Koppaka V,, Robertson DM. The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium. Am J Path. 2014; 184: 2662–2670.
- Jiucheng H,, Bazan HEP. Mapping the nerve architecture of diabetic human corneas. Ophthalmol. 2012; 119: 956–964.
- Ishida N,, Rao GN,, del Gerro M,, Aquavella JV. Corneal nerve alterations in diabetes mellitus. Arch Ophthalmol. 1984; 102: 1380–1384.
- Rosenberg ME,, Tervo TM,, Immonen IJ,, et al. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 2000; 41: 2915–2921.
- Malik RA,, Kallinikos P,, Abbott CA,, et al. Corneal confocal microscopy: A non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003; 46: 683–688.
- Sheedy JE,, Truong SD,, Hayes JR. What are the visual benefits of eyelid squinting? Optom Vis Sci. 2003; 80: 740–744.
- Oh BL,, Suh SY,, Choung HK,, Kim SJ. Squinting and photophobia in intermittent exotropia. Optom Vis Sci. 2014; 91: 533–539.
- Rahman M,, Okamoto K,, Thompson R,, Bereiter DA. Trigeminal pathways for hypertonic saline- and light-evoked corneal reflexes. Neurosci. 2014; 26: 716–723.
- Shaheen BS,, Bakir M,, Jain S. Corneal nerves in health and disease. Survey Opththalmol. 2014; 59: 263–285.
- Belmonte C. Carmen Acosta M Merayo-Lloves J, Gallar J. What causes eye pain? Curr Ophthalmol Rep. 2015; 3: 111–121.
- Alamri A,, Bron R,, Brock JA,, Ivanusic JJ. Transient receptor potential cation channel subfamily V member 1 expressing corneal sensory neurons can be subdivided into at least three subpopulations. Front Neuroanat. 2015; 9: 1–13.
- Kurose M,, Meng ID. Dry eye modifies the thermal and menthol responses in rat corneal primary afferent cool cells. J Neurophysiol. 2013; 110: 495–504.
- Madrid R,, Donovan-Rodriguer T,, Meseguer V,, Acosta MC,, Belmonte C,, Viana F. Contribution of TRPM8 channels to cold transduction in primary sensory neurons and peripheral nerve terminals. J Neurosci. 2006; 26: 12512–12525.
Source: PubMed